By Professor Kathy Petoumenos

Journal articles

Hajarizadeh B; Grebely J; Applegate T; Matthews GV; Amin J; Petoumenos K; Hellard M; Rawlinson W; Lloyd A; Kaldor J; Dore GJ; Dolan K, 2014, 'Dynamics of HCV RNA Levels During Acute Hepatitis C Virus Infection', Journal of Medical Virology, 86, pp. 1722 - 1729, http://dx.doi.org/10.1002/jmv.24010

Wright ST; Hoy J; Mulhall B; OʼConnor CC; Petoumenos K; Read T; Smith D; Woolley I; Boyd MA; O'Connor C, 2014, 'Determinants of Viremia Copy-Years in People With HIV/AIDS After Initiation of Antiretroviral Therapy', JAIDS Journal of Acquired Immune Deficiency Syndromes, 66, pp. 55 - 64, http://dx.doi.org/10.1097/qai.0000000000000125

Miller CJ; Baker JV; Bormann AM; Erlandson KM; Hullsiek KH; Justice AC; Neuhaus J; Paredes R; Petoumenos K; Wentworth D; Winston A; Wolfson J; Neaton JD; Emery S, 2014, 'Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy', PLoS ONE, 9, pp. e95061, http://dx.doi.org/10.1371/journal.pone.0095061

Kamara DA; Ryom L; Ross M; Kirk O; Reiss P; Morlat P; Moranne O; Fux CA; Mocroft A; Sabin C; Lundgren JD; Smith CJ; Powderly B; Shortman N; Moecklinghoff C; Reilly G; Franquet X; Ryom L; Sabin CA; Kamara D; Smith C; Phillips A; Mocroft A; Tverland J; Mansfeld M; Nielsen J; Raben D; Lundgren JD; Salbøl Brandt R; Rickenbach M; Fanti I; Krum E; Hillebregt M; Geffard S; Sundström A; Delforge M; Fontas E; Torres F; McManus H; Wright S; Kjær J; Sjøl A; Meidahl P; Helweg-Larsen J; Schmidt Iversen J; Mocroft A; Kirk O; Ross M; Fux CA; Morlat P; Kesselring AM; Kamara DA; Smith C; Lundgren JD; Smith C; Phillips A; Weber R; Morlat P; Pradier C; Friis-Møller N; Kowalska J; Lundgren JD; Sabin C; Law M; D'Arminio Monforte A; Dabis F; Bruyand M; Smith C; Bower M; Fätkenheuer G; Donald A; Grulich A; Lundgren JD; Zaheri S; Gras L; Prins JM; Kuijpers TW; Scherpbier HJ; Van Der Meer JTM; Wit FWMN; Godfried MH; Reiss P; Van Der Poll T; Nellen FJB; Lange JMA; Geerlings SE; Van Vugt M; Pajkrt D; Bos JC; Van Der Valk M, 2014, 'Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study', BMC Nephrology, 15, http://dx.doi.org/10.1186/1471-2369-15-51

McManus H; Petoumenos K; Franic T; Kelly MD; Watson J; O’Connor CC; Jeanes M; Hoy J; Cooper DA; Law MG; O'Connor C; Templeton D; Han A, 2014, 'Determinants of Suicide and Accidental or Violent Death in the Australian HIV Observational Database', PLoS ONE, 9, pp. e89089 - e89089, http://dx.doi.org/10.1371/journal.pone.0089089

Mulhall BP; Wright S; Allen D; Brown K; Dickson B; Grotowski M; Jackson E; Petoumenos K; Read P; Read T; Russell D; Smith DJ; Templeton DJ; Fairley CK; Law MG; Han A, 2014, 'High rates of sexually transmissible infections in HIV-positive patients in the Australian HIV Observational Database: A prospective cohort study', Sexual Health, 11, pp. 291 - 297, http://dx.doi.org/10.1071/SH13074

Achhra AC; Petoumenos K; Law MG, 2014, 'Relationship between CD4 cell count and serious long-term complications among HIV-positive individuals', Current Opinion in HIV and AIDS, 9, pp. 63 - 71, http://dx.doi.org/10.1097/COH.0000000000000017

Petoumenos K; Reiss P; Ryom L; Rickenbach M; Sabin CA; El-Sadr W; d'Arminio Monforte A; Phillips AN; De Wit S; Kirk O; Dabis F; Pradier C; Lundgren JD; Law MG, 2014, 'Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: A comparison of the D: A: D CVD risk equation and general population CVD risk equations', HIV Medicine, http://dx.doi.org/10.1111/hiv.12162

Rafiee M; Kariminia A; Wright S; Mills G; Woolley I; Smith D; Templeton DJ; Law MG; Petoumenos K, 2014, 'Reducing Viral Load Measurements to Once a Year in Patients on Stable, Virologically Suppressive Cart Regimen: Findings from the Australian HIV Observational Database', Journal of AIDS & Clinical Research, 5, pp. 383, http://dx.doi.org/10.4172/2155-6113.1000383

Feld JJ; Grebely J; Matthews GV; Applegate T; Hellard M; Sherker A; Cherepanov V; Petoumenos K; Yeung B; Kaldor JM; Lloyd AR; Dore GJ, 2013, 'Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection', PLoS ONE, 8, pp. e80003, http://dx.doi.org/10.1371/journal.pone.0080003

Worm SW; Bower M; Reiss P; Bonnet F; Law M; Fätkenheuer G; d'Arminio Monforte A; Abrams DI; Grulich A; Fontas E; Kirk O; Furrer H; Wit SD; Phillips A; Lundgren JD; Sabin CA; Butcher D; Delforge M; Fanti I; Franquet X; Geffard S; Gras L; Helweg-Larsen J; Hillebregt M; Kamara D; Kjær J; Krum E; McManus H; Meidahl P; Mocroft A; Nielsen J; Powderl W; Rickenbach M; Rode R; Ryom L; Salbøl Brandt R; Schmidt Iversen J; Shortman N; Sjøl A; Smith C; Torres F; Tverland J; Wright S; Zaheri S; de Wolf F; Smidt J; Ristola M; Katlama C; Viard JP; Girard PM; Livrozet JM; Vanhems P; Pradier C; Dabis F; Neau D; Rockstroh J; Schmidt R; Degen O; van Lunzen J; Stellbrink HJ; Staszewski S; Bogner J; Gargalianos P; Kosmidis J; Perdios J; Xylomenos G; Filandras A; Karabatsaki E; Panos G; Sambatakou H; Banhegyi D; Mulcahy F; Burke M; Turner D; Yust I; Hassoun G; Pollack S; Maayan S; Vella S; Esposito R; Mazeu I; Mussini C; Arici C; Pristera R; Gabbuti A; Mazzotta F; Lichtner M; Vullo V; Boer K; Geerlings SE; Godfried MH; Kuijpers TW; Lange JMA; Nellen FJB; Pajkrt D; Prins JM; Scherpbier HJ; Vrouenraets SME; Wit FWMN; van Vugt M; Cooper D; Petoumenos K; Carr A; Bloch M; Han A, 2013, 'Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study', BMC Infectious Diseases, 13, pp. 471, http://dx.doi.org/10.1186/1471-2334-13-471

Rotger M; Glass TR; Junier T; Lundgren J; Neaton JD; Poloni ES; Van 'T Wout AB; Lubomirov R; Colombo S; Martinez R; Rauch A; Günthard HF; Neuhaus J; Wentworth D; Van Manen D; Gras LA; Schuitemaker H; Albini L; Torti C; Jacobson LP; Li X; Kingsley LA; Carli F; Guaraldi G; Ford ES; Sereti I; Hadigan C; Martinez E; Arnedo M; Egaña-Gorroño L; Gatell JM; Law M; Bendall C; Petoumenos K; Rockstroh J; Wasmuth JC; Kabamba K; Delforge M; De Wit S; Berger F; Mauss S; De Paz Sierra M; Losso M; Belloso WH; Leyes M; Campins A; Mondi A; De Luca A; Bernardino I; Barriuso-Iglesias M; Torrecilla-Rodriguez A; Gonzalez-Garcia J; Arribas JR; Fanti I; Gel S; Puig J; Negredo E; Gutierrez M; Domingo P; Fischer J; Fätkenheuer G; Alonso-Villaverde C; MacKen A; Woo J; McGinty T; Mallon P; Mangili A; Skinner S; Wanke CA; Reiss P; Weber R; Bucher HC; Fellay J; Telenti A; Tarr PE, 2013, 'Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons', Clinical Infectious Diseases, 57, pp. 112 - 121, http://dx.doi.org/10.1093/cid/cit196

Byakwaga H; Petoumenos K; Ananworanich J; Zhang F; Boyd MA; Sirisanthana T; Li PCK; Lee C; Mean CV; Saphonn V; Omar SFS; Pujari S; Phanuphak P; Lim PL; Kumarasamy N; Chen YMA; Merati TP; Sungkanuparph S; Ditangco R; Oka S; Tau G; Zhou J; Law MG; Emery S; Han A, 2013, 'Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: Results from the TREAT Asia HIV Observational Database', Journal of the International Association of Providers of AIDS Care, 12, pp. 270 - 277, http://dx.doi.org/10.1177/1545109712469684

Wright S; Boyd MA; Yunihastuti E; Law M; Sirisanthana T; Hoy J; Pujari S; Lee MP; Petoumenos K; Templeton D; Han A, 2013, 'Rates and Factors Associated with Major Modifications to First-Line Combination Antiretroviral Therapy: Results from the Asia-Pacific Region', PLoS ONE, 8, pp. e64902, http://dx.doi.org/10.1371/journal.pone.0064902

Grebely J; Feld JJ; Applegate T; Matthews GV; Hellard M; Sherker A; Petoumenos K; Zang G; Shaw I; Yeung B; George J; Teutsch S; Kaldor JM; Cherepanov V; Bruneau J; Shoukry NH; Lloyd AR; Dore GJ, 2013, 'Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection', Hepatology, 57, pp. 2124 - 2134, http://dx.doi.org/10.1002/hep.26263

Jansson J; Wilson DP; Carr A; Petoumenos K; Boyd MA, 2013, 'Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV', AIDS, 27, pp. 1245 - 1251, http://dx.doi.org/10.1097/QAD.0b013e32835e163d

Wright ST; Petoumenos K; Boyd MA; Carr AD; Downing S; O''connor C; Grotowski M; Law MG, 2013, 'Ageing and long-term CD4 cell count trends in HIV-positive patients with 5 years or more combination antiretroviral therapy experience', HIV Medicine, 14, pp. 208 - 216, http://dx.doi.org/10.1111/j.1468-1293.2012.01053.x

Kovari H; Sabin CA; Ledergerber B; Ryom L; Smith C; Phillips A; Reiss P; Fontas E; Petoumenos K; De Wit S; Morlat P; Lundgren JD; Weber R, 2013, 'Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: The data collection on adverse events of anti-HIV drugs study', Clinical Infectious Diseases, 56, pp. 870 - 879, http://dx.doi.org/10.1093/cid/cis919

Petoumenos K; Van Leeuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG, 2013, 'Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD)', HIV Medicine, 14, pp. 77 - 84, http://dx.doi.org/10.1111/j.1468-1293.2012.01038.x

Jansson J; Wilson D; Carr A; Petoumenos K; Boyd M, 2012, 'Currently available medications may not be sufficient for lifelong treatment of HIV', JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 15, pp. 4 - 4, http://dx.doi.org/10.7448/IAS.15.6.18077

Grebely J; Alavi M; Spelman T; Haber P; Day C; Matthews G; Van Beek I; Walsh N; Yeung B; Petoumenos K; Dolan K; Kaldor J; Dore G; Hellard M, 2012, 'IMPACT OF TREATMENT OF RECENTLY-ACQUIRED HEPATITIS C INFECTION ON INJECTING DRUG USE BEHAVIOURS', DRUG AND ALCOHOL REVIEW, 31, pp. 34 - 34

Machalek DA; Poynten IM; Jin F; Fairley CK; Farnsworth A; Garland S; Hillman R; Petoumenos K; Roberts J; Tabrizi S; Templeton DJ; Grulich AE, 2012, 'Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: A systematic review and meta-analysis', Lancet Oncology, 13, pp. 487 - 500, http://dx.doi.org/10.1016/S1470-2045(12)70080-3

Grebely J; Matthews GV; Petoumenos K; Yeung B; Day C; Lloyd AR; Beek IV; Kaldor JM; Hellard M; Dore GJ; Haber PS; Alavi M; Van Beek I; Amin J; Dolan K; Rawlinson W; Flynn J; Marks P; Acraman B; Bloch M; Li H; Madden A; George J, 2012, 'Effect of pegylated interferon-a-2a treatment on mental health during recent hepatitis C virus infection', Journal of Gastroenterology and Hepatology, 27, pp. 957 - 965, http://dx.doi.org/10.1111/j.1440-1746.2011.07035.x

, 2012, 'Eleventh International Congress on Drug Therapy in HIV Infection', Journal of the International AIDS Society, 15, pp. 18447 - 18447, http://dx.doi.org/10.7448/ias.15.6.18447

Grebely J; Pham ST; Matthews G; Petoumenos K; Bull RA; Yeung B; Rawlinson WD; Kaldor JM; Lloyd AR; Hellard M; Dore GJ; White PA; Bull ; Dolan K, 2012, 'Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection', Hepatology, 55, pp. 1058 - 1069, http://dx.doi.org/10.1002/hep.24754

McManus H; O'Connor CC; Boyd MA; Broom J; Russell D; Watson K; Roth N; Read PJ; Law M; Petoumenos K; Templeton D; Han A, 2012, 'Long-term survival in HIV positive patients with up to 15 years of antiretroviral therapy', PLoS One, 7, pp. Article numbere48839, http://dx.doi.org/10.1371/journal.pone.0048839

Petoumenos K; Worm SW; Fontas E; Weber R; De Wit S; Bruyand M; Reiss P; El-Sadr W; Monforte AD; Friis-Moller N; Lundgren JD; Law MG; Law M; Han A, 2012, 'Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study', Journal of the International AIDS Society, 15, pp. Article number17426, http://dx.doi.org/10.7448/IAS.15.2.17426

Grebely J; Hellard M; Applegate TL; Petoumenos K; Yeung B; Feld J; Rawlinson WD; Lloyd AR; George J; Kaldor JM; Dore GJ; Matthews G; Dolan K, 2012, 'Virological responses during treatment for recent hepatitis C virus: Potential benefit for ribavirin use in HCV/HIV co-infection', AIDS, 26, pp. 1653 - 1661, http://dx.doi.org/10.1097/QAD.0b013e3283553719

Grebely J; Matthews G; Hellard M; Shaw D; van Beek I; Petoumenos K; Alavi M; Yeung B; Haber P; Lloyd AR; Kaldor JM; Dore GJ; Dolan K, 2011, 'Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users', Journal of Hepatology, 55, pp. 76 - 85, http://dx.doi.org/10.1016/j.jhep.2010.10.033

Rajasuriar R; Gouillou M; Spelman T; Read T; Hoy JF; Law MG; Cameron P; Petoumenos K; Lewin S, 2011, 'Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the australian HIV observational database', PLoS One, 6, pp. e20713, http://dx.doi.org/10.1371/journal.pone.0020713

McManus H; Lim P; Nolan D; Bloch M; Kiertiburanakul S; Choi J; Mulhall BP; Petoumenos K; Zhou J; Law MG; Brew BJ; Wright E, 2011, 'Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?', HIV Medicine, 12, pp. 610 - 619, http://dx.doi.org/10.1111/j.1468-1293.2011.00938.x

Worm SW; Kamara DA; Reiss P; Kirk O; El-Sadr W; Fux C; Fontas E; Phillips A; D''arminio Monforte A; De Wit S; Petoumenos K; Friis-Moller N; Mercie P; Lundgren JD; Sabin C, 2011, 'Elevated triglycerides and risk of myocardial infarction in HIV-positive persons', AIDS, 25, pp. 1497 - 1504, http://dx.doi.org/10.1097/QAD.0b013e32834917c6

Bunupuradah T; Ananworanich J; Chetchotisakd P; Kantipong P; Jirajariyavej S; Sirivichayakul S; Munsakul W; Prasithsirikul W; Sungkanuparph S; Bowonwattanuwong C; Klinbuayaem V; Petoumenos K; Hirschel B; Bhakeecheep S; Ruxrungtham K, 2011, 'Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens', Antiviral Therapy, 16, pp. 1113 - 1121, http://dx.doi.org/10.3851/IMP1906

Van Bockel DJ; Ammaranond P; Petoumenos K; Mcmurchie M; Finlayson RJ; Middleton MG; Davenport ; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD, 2011, 'HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome', Journal of Immunology, 186, pp. 479 - 488, http://www.jimmunol.org/content/186/1/479

Petoumenos K; Worm SW, 2011, 'HIV infection, ageing and cardiovascular disease: Epidemiology and prevention', Sexual Health, 8, pp. 465 - 473, http://search.informit.com.au/documentSummary;dn=535450990470779;res=IELHEA

Bunupuradah T; Ananworanich J; Pancharoen C; Petoumenos K; Prasitsuebsai W; Wongngam W; Ubolyam S; Sriheara C; Lange J; Phanuphak P; Puthanakit T, 2011, 'Randomized study of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children without severe immunosuppression', Vaccine, 29, pp. 2962 - 2967, http://dx.doi.org/10.1016/j.vaccine.2011.01.114

Petoumenos K; Worm S; Reiss P; De Wit S; D''arminio monforte A; Sabin C; Friis-Moller N; Weber R; Mercie P; Pradier C; El-Sadr W; Kirk O; Lundgren JD; Law MG, 2011, 'Rates of cardiovascular disease following smoking cessation in patients with HIV infection: Results from the D:A:D study', HIV Medicine, 12, pp. 412 - 421, http://dx.doi.org/10.1111/j.1468-1293.2010.00901.x

Achhra AC; Zhou J; Choi JY; Hoy J; Zhang F; Templeton DJ; Merati T; Woolley I; Petoumenos K; Amin J, 2011, 'The clinical significance of CD4 counts in asian and caucasian HIV-infected populations: Results from TAHOD and AHOD', Journal of the International Association of Physicians in AIDS Care, 10, pp. 160 - 170, http://dx.doi.org/10.1177/1545109711402213

Law MG; Woolley I; Templeton DJ; Roth N; Chuah J; Mulhall BP; Canavan P; Mcmanus H; Cooper DA; Petoumenos K, 2011, 'Trends in detectable viral load by calendar year in the Australian HIV observational database', Journal of the International AIDS Society, 14, pp. 10, http://dx.doi.org/10.1186/1758-2652-14-10

Marashi Pour S; Woolley I; Canavan P; Chuah J; Russell DB; Law MG; Petoumenos K, 2011, 'Triple Class Experience after Initiation of Combination Antiretroviral Treatment in Australia: Survival and Projections', Sexual Health, 8, pp. 295 - 303, http://search.informit.com.au/documentSummary;dn=359164449396949;res=IELHEA

Grebely J; Matthews GV; Petoumenos K; Dore GJ, 2010, 'Spontaneous clearance and the beneficial impact of treatment on clearance during recent hepatitis C virus infection', Journal of Viral Hepatitis, 17, pp. 896, http://dx.doi.org/10.1111/j.1365-2893.2009.01256.x

Molano M; Tabrizi SN; Garland SM; Roberts JM; MacHalek DA; Phillips S; Chandler D; Hillman RJ; Grulich AE; Jin F; Poynten IM; Templeton DJ; Cornall AM; McCaffery K; Howard K; Farnsworth A; Fairley K; Prestage G; Carr A; Tong W; Law C; Acraman B; Crampton L; Feeney L; Fraissard E; Law M; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Varma R; Han A, 2010, 'CpG methylation analysis of hpv16 in laser capture microdissected archival tissue and whole tissue sections from high grade anal squamous intraepithelial lesions: A potential disease biomarker', PLoS ONE, 11, pp. e0160673, http://dx.doi.org/10.1371/journal.pone.0160673

Grebely J; Petoumenos K; Matthews G; Haber PS; Marks P; Lloyd AROLA; Kaldor JM; Dore GJ; Hellard M; Dolan K, 2010, 'Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study', Drug and Alcohol Dependence, 107, pp. 244 - 249, http://dx.doi.org/10.1016/j.drugalcdep.2009.09.015

Petoumenos K; Hui E; Kumarasamy N; Kerr SJ; Choi JY; Chen YF; Merati T; Zhang F; Lim P; Sungkanuparph S; Pujari S; Ponnampalavanar S; Ditangco R; Lee CK; Grulich AE; Law MG, 2010, 'Cancers in the Treat Asia HIV Observational Database (TAHOD): A retrospective analysis of risk factors', Journal of the International AIDS Society, 13, pp. 1 - 14, http://www.jiasociety.org/content/13/1/51

Winston A; Duncombe C; Li P; Gill JM; Kerr SJ; Puls R; Petoumenos K; Taylor-Robinson SD; Emery S; Cooper DA, 2010, 'Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study', Clinical Infectious Diseases, 50, pp. 920 - 929

Puls R; Srasuebkul P; Petoumenos K; Boesecke C; Duncombe CJ; Belloso WH; Molina J; Li L; Avihingsanon A; Gazzard B; Cooper DA; Emery S, 2010, 'Efavirenz versus boosted atazanavir or zidovudine and abacavir in antirectroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study', Clinical Infectious Diseases, Oct 1; 51, pp. 855 - 864

Dore GJ; Hellard M; Matthews G; Grebely J; Haber PS; Petoumenos K; Yeung B; Marks P; Van Beek IA; McCaughan G; White PA; French R; Rawlinson WD; Lloyd AROLA; Kaldor JM; Dolan K, 2010, 'Effective treatment of injecting drug users with recently acquired hepatitis C virus infection', Gastroenterology, 138, pp. 123 - 135, http://dx.doi.org/10.1053/j.gastro.2009.09.019

Carey DL; Amin J; Boyd MA; Petoumenos K; Emery S, 2010, 'Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomised controlled trials', Journal of Antimicrobial Chemotherapy, 65, pp. 1878 - 1888

Grebely J; Petoumenos K; Hellard M; Matthews G; Suppiah V; Applegate TL; Yeung B; Marks P; Rawlinson WD; Lloyd AROLA; Booth D; Kaldor JM; George J; Dore GJ; Amin J; Cameron B; Acraman B; Dolan K; Bloch M; Van Beek I; Li H; Madden A, 2010, 'Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection', Hepatology, 52, pp. 1216 - 1224, http://dx.doi.org/10.1002/hep.23850

Haber P; Hellard M; Matthews GV; Grebely J; Petoumenos K; Yeung B; Marks P; Van Beek I; Kaldor J; Dore GJ, 2009, 'TREATMENT OF RECENT HEPATITIS C VIRUS INFECTION IN A PREDOMINANTLY INJECTION DRUG USER COHORT: THE ATAHC STUDY', DRUG AND ALCOHOL REVIEW, 28, pp. A27 - A27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page